Giulia Rovesti

777 total citations
27 papers, 393 citations indexed

About

Giulia Rovesti is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giulia Rovesti has authored 27 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giulia Rovesti's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer, Lipids, and Metabolism (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Giulia Rovesti is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer, Lipids, and Metabolism (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Giulia Rovesti collaborates with scholars based in Italy, United States and Sweden. Giulia Rovesti's co-authors include Andrea Casadei‐Gardini, Giulia Orsi, Massimo Dominici, Francesco Giuseppe Foschi, Alessandra Recchia, Edwin M. Horwitz, Margherita Rimini, Elena Veronesi, Giulia Grisendi and Filippo Rossignoli and has published in prestigious journals such as Gut, Journal of Hepatology and Annals of Oncology.

In The Last Decade

Giulia Rovesti

25 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giulia Rovesti Italy	11	162	123	88	85	70	27	393
Xiaoju Shi China	13	128 0.8×	126 1.0×	89 1.0×	69 0.8×	88 1.3×	35	415
Guoyang Wu China	11	94 0.6×	159 1.3×	72 0.8×	100 1.2×	93 1.3×	32	452
Silvia Camera Italy	10	164 1.0×	96 0.8×	74 0.8×	71 0.8×	102 1.5×	27	388
Guo Long China	13	170 1.0×	213 1.7×	91 1.0×	165 1.9×	94 1.3×	26	492
Xiongying Jiang China	13	124 0.8×	76 0.6×	173 2.0×	75 0.9×	84 1.2×	38	498
Nguyen H. Tran United States	11	249 1.5×	147 1.2×	97 1.1×	122 1.4×	74 1.1×	59	470
Monica Capozzi Italy	11	239 1.5×	133 1.1×	32 0.4×	94 1.1×	122 1.7×	22	434
Zhi-Qiang Meng China	12	213 1.3×	214 1.7×	97 1.1×	126 1.5×	77 1.1×	16	483
Norifumi Iseda Japan	13	171 1.1×	147 1.2×	104 1.2×	180 2.1×	56 0.8×	54	498

Countries citing papers authored by Giulia Rovesti

Since Specialization

Citations

This map shows the geographic impact of Giulia Rovesti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Rovesti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Rovesti more than expected).

Fields of papers citing papers by Giulia Rovesti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Rovesti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Rovesti. The network helps show where Giulia Rovesti may publish in the future.

Co-authorship network of co-authors of Giulia Rovesti

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Rovesti. A scholar is included among the top collaborators of Giulia Rovesti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Rovesti. Giulia Rovesti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Curtis, Daniela Nascimento Silva, Ola B. Nilsson, et al.. (2025). Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation. Gut. 74(7). 1125–1136.

Rovesti, Giulia, Giovanni Neri, Giuseppe Pugliese, et al.. (2025). CAR-T for Lung Cancers: Challenges and Innovations. Lung Cancer. 207. 108711–108711. 1 indexed citations

Rovesti, Giulia, et al.. (2024). 462P Regorafenib for relapsed glioblastoma: Retrospective real-world analysis of a single Institution experience. Annals of Oncology. 35. S414–S414. 1 indexed citations

Silva, Daniela Nascimento, Michael Chrobok, Giulia Rovesti, et al.. (2022). Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products. Frontiers in Immunology. 13. 896242–896242. 10 indexed citations

Garajová, Ingrid, Giulia Rovesti, Rita Balsano, et al.. (2021). The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review. Pharmaceuticals. 14(1). 43–43. 9 indexed citations

Rovesti, Giulia, Giorgia Marisi, & Andrea Casadei‐Gardini. (2021). Recent Research on Gastrointestinal Carcinoma. Cancers. 13(2). 333–333.

Casadei‐Gardini, Andrea, Laura Del Coco, Giorgia Marisi, et al.. (2020). 1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages. Cancers. 12(1). 241–241. 43 indexed citations

Spallanzani, Andrea, et al.. (2020). 1746P Impact of PD-1/PD-L1 blockade therapy in COVID-19 infected cancer patients (pts) hospitalization: Results of an Italian study in the province of Modena and Reggio Emilia during SARS-CoV-2 outbreak. Annals of Oncology. 31. S1019–S1020. 3 indexed citations

Casadei‐Gardini, Andrea, Giulia Rovesti, Vincenzo Dadduzio, et al.. (2020). Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib. HPB. 23(6). 915–920. 16 indexed citations

10.

Casadei‐Gardini, Andrea, Fabio Gelsomino, Andrea Spallanzani, et al.. (2020). Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-Analysis. Clinical Colorectal Cancer. 19(2). 82–90.e9. 9 indexed citations

11.

Vivaldi, Caterina, Francesca Salani, Giulia Rovesti, et al.. (2020). First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?. European Journal of Cancer. 137. 108–116. 11 indexed citations

12.

Molinaro, Eleonora, Kalliopi Andrikou, Andrea Casadei‐Gardini, & Giulia Rovesti. (2020). BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives. Cancers. 12(11). 3346–3346. 13 indexed citations

13.

Rimini, Margherita, Andrea Casadei‐Gardini, Alessandra Ravaioli, et al.. (2020). Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study. Journal of Clinical Medicine. 9(4). 1177–1177. 21 indexed citations

14.

Casadei‐Gardini, Andrea, Vincenzo Dadduzio, Giulia Rovesti, et al.. (2020). Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib. Medicine. 99(22). e19958–e19958. 7 indexed citations

15.

Casadei‐Gardini, Andrea, Emanuela Scarpi, Martina Valgiusti, et al.. (2020). Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial. Therapeutic Advances in Medical Oncology. 12. 22 indexed citations

16.

Rovesti, Giulia, Giulia Orsi, Luca Faloppi, et al.. (2019). Sorafenib in patients with hepatocellular carcinoma: 10 years of real life. Annals of Oncology. 30. iv57–iv57. 1 indexed citations

17.

Tovoli, Francesco, Luca Ielasi, Andrea Casadei‐Gardini, et al.. (2019). Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients. Journal of Hepatology. 71(6). 1175–1183. 61 indexed citations

18.

Marisi, Giorgia, Vincenzo Dadduzio, Luca Ielasi, et al.. (2019). Multicentric prospective study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: results of INNOVATE study. Annals of Oncology. 30. iv113–iv113. 1 indexed citations

19.

Rossignoli, Filippo, Carlotta Spano, Giulia Grisendi, et al.. (2019). MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma. Theranostics. 9(2). 436–448. 43 indexed citations

20.

Rossignoli, Filippo, Giulia Grisendi, Carlotta Spano, et al.. (2018). Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy. Cancer Gene Therapy. 26(1-2). 11–16. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact